EDGAR Filing Documents for 0001094891-16-000433

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001094891-16-000433

Filing Date

2016-03-18

Accepted

2016-03-18 14:55:25

Documents

Period of Report

2016-03-16

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	edgar.html	4
1	PRIMARY DOCUMENT	edgar.xml	4	5923
	Complete submission text file	0001094891-16-000433.txt		8109

Mailing Address 375 PARK AVE NEW YORK NY 10152

Business Address

ROSENWALD LINDSAY A MD (Reporting) CIK: 0000941841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36757 | Film No.: 161515845

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019

Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 781-652-4500

Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36757 | Film No.: 161515844
SIC: 2834 Pharmaceutical Preparations

Mailing Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803

Business Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803 781-652-4500

CB Pharma Acquisition Corp. (Issuer) CIK: 0001619551 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1130
SIC: 6770 Blank Checks